ENDURO Trial Results, EASL Hepatitis B Guidelines 2025, AI in Endoscopy & IBS Biomarkers | Latest GI Updates

In this episode, we cover five crucial updates shaping gastroenterology and endoscopy practice in 2025. From the practice-changing ENDURO trial comparing endoscopic to surgical approaches for malignant gastric outlet obstruction, to the latest EASL hepatitis B management guidelines, AI applications in endoscopy, sedation innovations, and biomarker-driven approaches to IBS.

Resources & Links

ENDURO Trial & EUS-Guided Gastroenterostomy

• ENDURO Study Protocol - Trials Journal
• ENDURO Trial Results - The Lancet Gastroenterology & Hepatology
• EUS-GE Overview - Gastroenterology & Endoscopy News
• Prospective Study - Gastrointestinal Endoscopy

EASL 2025 Hepatitis B Guidelines

• EASL HBV Guidelines 2025 - Journal of Hepatology
• EASL Guidelines Summary - EASL Website
• HBV Guidelines PDF - Hepatitis B Foundation

AI in Endoscopy

• AI and Polyp Detection Review - PMC
• AI-Assisted Colonoscopy Meta-Analysis - Annals of Internal Medicine
• Use of AI in Colonoscopy - Gastrointestinal Endoscopy
• Endoscopist Deskilling Study - The Lancet
• Bibliometric Analysis - Frontiers in Medicine

Sedation Innovations

• Remimazolam Review - Clinical Endoscopy
• Remimazolam vs Propofol Meta-Analysis - British Journal of Anaesthesia
• Remimazolam Comprehensive Review - World Journal of GI Endoscopy
• Remimazolam Real-World Study - BMC Gastroenterology
• Safety and Efficacy Comparison - BMC Anesthesiology

IBS Biomarkers & Microbiome

• 2025 Seoul Consensus on IBS - PMC
• 16S rRNA Microbiome Biomarkers for IBS - PMC
• International Consensus on Microbiome Testing - Gut Microbiota for Health
• Gut Microbiome Resilience Review - Frontiers in Microbiology

This podcast is for educational purposes only and does not constitute medical advice. Always consult current guidelines and use clinical judgment when making treatment decisions.

https://www.gastroendopod.com